Formic Acid

Formic Acid

SCHEMBL4911299

CCN1CCCC(O)(c2ccccc2C(S)c2cccc3ccccc23)C1.O=CO

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.33
HSD17B10 Q99714 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.32
KMT2A Q03164 2/20 0.32
SLC6A2 P23975 2/20 0.32
SLC6A4 P31645 2/20 0.32
SLC6A3 Q01959 2/20 0.32
CBX7 O95931 1/20 0.31
CDY1; CDY1B Q9Y6F8 1/20 0.31
HSD11B1 P28845 2/20 0.31
DRD2 P14416 1/20 0.31
DRD4 P21917 1/20 0.31
DRD3 P35462 1/20 0.31
TMEM97 Q5BJF2 2/20 0.31
SIGMAR1 Q99720 2/20 0.31
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
OPRK1 P41145 1/20 0.31
CDYL Q9Y232 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6743664 0.95 TSHR (0.35) KDM4EHSD17B10ALDH1A1TSHRKMT2A
Formic Acid SCHEMBL4911312 0.78 SMN1; SMN2 (0.35) KDM4EHSD17B10ALDH1A1TSHRKMT2A
SCHEMBL6743192 0.74 OPRM1 (0.39) KDM4EHSD17B10ALDH1A1TSHRKMT2A
SCHEMBL4818176 0.71 MAPT (0.35) KDM4EHSD17B10ALDH1A1TSHRDRD2
SCHEMBL6742634 0.68 SLC6A4 (0.51) KDM4EALDH1A1TSHRKMT2ASLC6A2
SCHEMBL9046812 0.67 KDM4E (0.51) KDM4EHSD17B10ALDH1A1TSHRKMT2A
SCHEMBL11224937 0.66 DRD3 (0.43) KDM4EDRD2DRD4DRD3OPRM1
SCHEMBL10643008 0.65 OPRL1 (0.47) KDM4EKMT2AHSD11B1DRD2DRD4
Hydrochloric Acid SCHEMBL10652811 0.64 POLB (0.49) KDM4EKMT2AHSD11B1DRD2DRD4
SCHEMBL4911308 0.63 MAPT (0.35) KDM4EHSD17B10ALDH1A1KMT2ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269217-A1 Melanocortin-4 receptor binding compounds and methods of use thereof ORE PHARMACEUTICALS, INC. (US) 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269217-A1 Melanocortin-4 receptor binding compounds and methods of use thereof MC4R, MC5R, MC3R KDM4E 1351/4885HSD17B10 1658/4885ALDH1A1 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.